Research ExplorerPublicationsRight heart transcatheter valve therapies - a review of pros...

Right heart transcatheter valve therapies - a review of prostheses for the pulmonary and tricuspid positions

Standard

Right heart transcatheter valve therapies - a review of prostheses for the pulmonary and tricuspid positions. / Kuetting, Maximilian; Pott, Desiree; Sedaghat, Alexander; Ng, Yue Ann; Egron, Sandrine; Rosefort, Christiane; Werner, Nikos; Sachweh, Joerg; Steinseifer, Ulrich.

In: Expert review of medical devices, Vol. 12, No. 2, 03.2015, p. 163-174.

Research output: SCORING: Contribution to journal › SCORING: Review article › Research

Harvard

Kuetting, M, Pott, D, Sedaghat, A, Ng, YA, Egron, S, Rosefort, C, Werner, N, Sachweh, J & Steinseifer, U 2015, 'Right heart transcatheter valve therapies - a review of prostheses for the pulmonary and tricuspid positions', Expert review of medical devices, vol. 12, no. 2, pp. 163-174. https://doi.org/10.1586/17434440.2015.985654

APA

Kuetting, M., Pott, D., Sedaghat, A., Ng, Y. A., Egron, S., Rosefort, C., Werner, N., Sachweh, J., & Steinseifer, U. (2015). Right heart transcatheter valve therapies - a review of prostheses for the pulmonary and tricuspid positions. Expert review of medical devices, 12(2), 163-174. https://doi.org/10.1586/17434440.2015.985654

Vancouver

Kuetting M, Pott D, Sedaghat A, Ng YA, Egron S, Rosefort C et al. Right heart transcatheter valve therapies - a review of prostheses for the pulmonary and tricuspid positions. Expert review of medical devices. 2015 Mar;12(2):163-174. https://doi.org/10.1586/17434440.2015.985654

Bibtex

@article{1435706acc1f4339adef3d76795c5432,
title = "Right heart transcatheter valve therapies - a review of prostheses for the pulmonary and tricuspid positions",
abstract = "Minimally invasive, catheter-based treatment of valvular dysfunction has become an integral part of clinical routine. As left heart valvular disease is much more common and thus commercially of interest, transcatheter solutions for the treatment of aortic and mitral valvular defects were the first to become broadly clinically available, while even today options for the right heart valve are rare. This review looks at innovative attempts at developing effective transcatheter heart valve prostheses for the pulmonary and tricuspid heart valves, details their experience and highlights those that have made their way to application in humans. ",
keywords = "Cardiac Catheterization, Clinical Trials as Topic, Heart Valve Prosthesis, Humans, Injections, Pulmonary Valve/physiopathology, Tricuspid Valve/physiopathology",
author = "Maximilian Kuetting and Desiree Pott and Alexander Sedaghat and Ng, {Yue Ann} and Sandrine Egron and Christiane Rosefort and Nikos Werner and Joerg Sachweh and Ulrich Steinseifer",
year = "2015",
month = mar,
doi = "10.1586/17434440.2015.985654",
language = "English",
volume = "12",
pages = "163--174",
journal = "EXPERT REV MED DEVIC",
issn = "1743-4440",
publisher = "Expert Reviews Ltd.",
number = "2",

}

RIS

TY - JOUR

T1 - Right heart transcatheter valve therapies - a review of prostheses for the pulmonary and tricuspid positions

AU - Kuetting, Maximilian

AU - Pott, Desiree

AU - Sedaghat, Alexander

AU - Ng, Yue Ann

AU - Egron, Sandrine

AU - Rosefort, Christiane

AU - Werner, Nikos

AU - Sachweh, Joerg

AU - Steinseifer, Ulrich

PY - 2015/3

Y1 - 2015/3

N2 - Minimally invasive, catheter-based treatment of valvular dysfunction has become an integral part of clinical routine. As left heart valvular disease is much more common and thus commercially of interest, transcatheter solutions for the treatment of aortic and mitral valvular defects were the first to become broadly clinically available, while even today options for the right heart valve are rare. This review looks at innovative attempts at developing effective transcatheter heart valve prostheses for the pulmonary and tricuspid heart valves, details their experience and highlights those that have made their way to application in humans.

AB - Minimally invasive, catheter-based treatment of valvular dysfunction has become an integral part of clinical routine. As left heart valvular disease is much more common and thus commercially of interest, transcatheter solutions for the treatment of aortic and mitral valvular defects were the first to become broadly clinically available, while even today options for the right heart valve are rare. This review looks at innovative attempts at developing effective transcatheter heart valve prostheses for the pulmonary and tricuspid heart valves, details their experience and highlights those that have made their way to application in humans.

KW - Cardiac Catheterization

KW - Clinical Trials as Topic

KW - Heart Valve Prosthesis

KW - Humans

KW - Injections

KW - Pulmonary Valve/physiopathology

KW - Tricuspid Valve/physiopathology

U2 - 10.1586/17434440.2015.985654

DO - 10.1586/17434440.2015.985654

M3 - SCORING: Review article

C2 - 25418630

VL - 12

SP - 163

EP - 174

JO - EXPERT REV MED DEVIC

JF - EXPERT REV MED DEVIC

SN - 1743-4440

IS - 2

ER -